Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Purple Biotech Ltd ADR (PPBT)

Purple Biotech Ltd ADR (PPBT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 131,007
  • Shares Outstanding, K 25,942
  • Annual Sales, $ 1,000 K
  • Annual Income, $ -28,000 K
  • 60-Month Beta 2.07
  • Price/Sales 129.45
  • Price/Cash Flow N/A
  • Price/Book 1.82
Trade PPBT with:

Options Overview

Details
  • Implied Volatility 129.59%
  • Historical Volatility 40.82%
  • IV Percentile 9%
  • IV Rank 16.92%
  • IV High 292.11% on 12/31/20
  • IV Low 96.49% on 05/07/21
  • Put/Call Vol Ratio 1.12
  • Today's Volume 53
  • Volume Avg (30-Day) 195
  • Put/Call OI Ratio 0.14
  • Today's Open Interest 3,509
  • Open Int (30-Day) 5,330

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.01
  • Number of Estimates 1
  • High Estimate -0.01
  • Low Estimate -0.01
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.38 +15.30%
on 08/19/21
5.18 -2.51%
on 09/13/21
+0.50 (+10.99%)
since 08/16/21
3-Month
4.27 +18.23%
on 07/07/21
5.82 -13.23%
on 07/29/21
-0.06 (-1.17%)
since 06/16/21
52-Week
3.60 +40.28%
on 04/16/21
7.25 -30.34%
on 02/10/21
+0.91 (+21.98%)
since 09/16/20

Most Recent Stories

More News
Purple Biotech Provides Corporate Update and Reports First Half 2021 Financial Results

Purple Biotech Ltd. ("Purple Biotech", or the "Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class, effective and durable therapies by overcoming tumor immune evasion and...

PPBT : 5.05 (+1.20%)
Thinking about buying stock in Senseonics, Xeris Pharmaceuticals, Purple Biotech, Targa Resources, or BlackBerry?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SENS, XERS, PPBT, TRGP, and BB.

SENS : 3.82 (-1.29%)
PPBT : 5.05 (+1.20%)
XERS : 2.53 (-0.78%)
BB : 10.16 (+0.30%)
TRGP : 46.22 (-1.05%)
Purple Biotech Presents New Clinical Data from NT219 at the 2021 ASCO Annual Meeting

Partial Response Observed in a Patient with Refractory Gastroesophageal Junction Cancer

PPBT : 5.05 (+1.20%)
Purple Biotech to Present at the Jefferies Virtual Healthcare Conference

Purple Biotech Ltd. ("Purple Biotech", or the "Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class, effective and durable therapies by overcoming tumor immune evasion and...

PPBT : 5.05 (+1.20%)
Purple Biotech to Present New Clinical Data from NT219 at the 2021 ASCO Annual Meeting

Initial Data from Ongoing Phase 1/2 Clinical Trial of NT219 in Adults with Advanced Solid Tumors and Head and Neck Cancer to be Highlighted

PPBT : 5.05 (+1.20%)
Purple Biotech Appoints Seasoned Biopharmaceutical Industry Executive Suzana Nahum-Zilberberg to Board of Directors

Purple Biotech Ltd. ("Purple Biotech" ", or the "Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class, effective and durable therapies by overcoming tumor immune evasion and...

PPBT : 5.05 (+1.20%)
Purple Biotech Announces Dosing of First Patient in Phase 1b/2 Clinical Trial of CM24 in Advanced Cancer Patients

Preliminary Data from First Part of Study Anticipated in Second Half of 2021

PPBT : 5.05 (+1.20%)
Purple Biotech Presents Additional Mechanism of Action Data for NT219 at American Association of Cancer Research 2021 Annual Meeting

Purple Biotech Ltd. ("Purple Biotech" ", or the "Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class, effective and durable therapies by overcoming tumor immune evasion and...

PPBT : 5.05 (+1.20%)
Purple Biotech Announces Initiation of Phase 1b/2 Clinical Trial of CM24 for Treatment of Multiple Advanced Cancers

Study Being Conducted in Clinical Collaboration with Bristol Myers Squibb

PPBT : 5.05 (+1.20%)
Purple Biotech to Present Additional Mechanism of Action Data for NT219 at American Association of Cancer Research 2021 Annual Meeting

Purple Biotech Ltd. ("Purple Biotech" ", or the "Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class, effective and durable therapies by overcoming tumor immune evasion and...

PPBT : 5.05 (+1.20%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Purple Biotech Ltd. is a clinical-stage company focusing on therapies to overcome tumor immune evasion and drug resistance. The Company's oncology pipeline includes NT219 and CM24. Purple Biotech Ltd., formerly known as Kitov Pharma Ltd., is based in TEL AVIV, Israel.

See More

Key Turning Points

3rd Resistance Point 5.35
2nd Resistance Point 5.22
1st Resistance Point 5.13
Last Price 5.05
1st Support Level 4.91
2nd Support Level 4.78
3rd Support Level 4.69

See More

52-Week High 7.25
Fibonacci 61.8% 5.86
Fibonacci 50% 5.43
Last Price 5.05
Fibonacci 38.2% 4.99
52-Week Low 3.60

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar